Objective
Beyond the huge public health implications, the HIV/AIDS epidemic is now threatening economic growth and national security in many countries, with worldwide implications. Although highly effective drug therapies have been a major breakthrough, the limitations of life-long continuous treatment are becoming apparent and these therapies are limited to patients with access to these drugs. Prophylactic vaccines are not expected to be available before 2010 and could only control infection. Hence the needs to develop Therapeutic Immunizations, which can boost the patients' own specific immune response to help control vire replication. Immunization with such a vaccine is an attractive strategy for treatment as it is simple, feasible on a global scale, and can be combined with drug therapy.
The Commission has recognized this and has made support available for European research in this field, but much of the expertise and intellectual capital is concentrated in large institutes in the USA. There is now a rare opportunity to attract a world-level expert, currently working in the USA, back to Europe to lead a European expertise centre on HIV infections. Prof Lisziewicz has worked at NIH with dr Gallo, one of the discoverers of the HIV virus, has established a leading Research Institute and is Professor at the renowned Georgetown University. Her grouphas developed an innovative therapeutic immunization program, which has been demonstrated in monkeys to work, and is now ready for the first clinical trials in patients. She has already established a small consortium to carry out immunological research, a clinical trial and obviously this program has even commercial exploitation potential.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine immunology immunisation
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences medical biotechnology nanomedicine
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences basic medicine immunology immunotherapy
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2002-MOBILITY-10
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
BUDAPEST
Hungary
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.